Effect of Extracorporeal Shock Wave on IL-32 and DKK-1 Levels in the Patients with Knee Osteoarthritis
1 Department of Orthopedics,Affiliated hospital of Logistics University of Chinese People's Armed Police Forces
2 Medical Team,7th Branch,Armed Police Forece of Shanghai
Abstract:Objective To observe the clinical efficacy of extracorporeal shock wave therapy combined with intra-articular injectioin of hyaluronate on knee osteoarthritis (KOA) and its effect on interleukin-32 (IL-32),Dickkopf-1 (DKK-1) in synovial fluid.Methods A total of 50 patients with knee osteoarthritis were randomly divided into two groups:treatment group (n=25) and control group (n=25).The control group was treated with intra-articular injection of sodium hyluronate alone,once per week for 5 weeks.The treatment group was treated with extracorporeal shock wave therapy on the basis of the control group,once per week for 5 weeks.Before intervention and 5th week after the intervention,the clinical efficacy in both groups were evaluated by Visual Analog Scale (VAS) on movement,Lequesne index and Western Ontario and McMaster Universities (WOMAC) Osteoarthritis index.The levels of IL-32,DKK-1 in synovial fluid were determined and compared.Results The socres of VAS,Lequesne index and WOMAC Osteoarthritis index after treatment in both groups were significantly lower than those before treatment (P<0.05).The socres of VAS,Lequesne index and WOMAC Osteoarthritis index after treatment in treatment group were significantly lower than those in the control group (P<0.05).Compared with before treatment,the levels of IL-32 in synovial fluid after treatment in both groups were significantly lower than those (all P<0.01).The levels of DKK-1 after treatment in the treatment group were significantly higher than that before treatment (P<0.01).The levels of IL-32 in synovial fluid after treatment in treatment group were significantly lower than that in the control group (P<0.05).The levels of DKK-1 were significantly higher than that in the control group (P<0.05).Conclusion The extracorporeal shock wave therapy combined with intra-articular injectioin of hyaluronate has significant curative effect.It can relieve the pain and improve the function of knee joint in the patients with KOA,which is correlated with decreased the levels of IL-32 and increased the levels of DKK-1 in synovial fluid.
[1]赵军,王庆甫,马玉峰,等.针刀联合玻璃酸钠与单纯玻璃酸钠治疗膝骨关节炎疗效的Meta分析[J].中国中医骨伤科杂志,2014,22(2):15-17;20.
[2]杨骁,周建林,彭昊.透明质酸治疗膝关节骨性关节炎的研究进展[J].安徽医药,2016,20(2):209-213.
[3]郭泰,宣雯霞,毕树雄.膝骨关节炎的治疗进展[J].中国药物与临床,2014,14(3):330-332.
[4]赵喆,史展,闫君,等.体外冲击波治疗早中期膝骨关节炎的效果[J].中国康复理论与实践,2014,20(1):76-78.
[5]黄志明,赵俊延,齐新文,等.IL-32和IL-18在人膝骨关节炎发病中的表达及意义[J].中国医学工程,2014,22(4):22-23.
[6]Corr M.Wnt-beta-catenin signaling in the pathogenesis of osteoarthritis[J].Nat Clin Pract Rheumatol,2008,4(10):550-556.
[7]Weng LH,Wang CJ,Ko JY,et al.Inflammation induction of Dickkopf-1 mediates chondrocyte apoptosis in osteoarthritic joint[J].Osteoarthritis Cartilage,2009,17(7):933-943.
[8]邱贵兴.骨关节炎诊治指南(2007版)[J].中华关节外科杂志,2007,1(4):281-284.
[9]侯晓东,刘洪柏,刘克敏.体外冲击波对兔膝骨关节炎软骨白细胞介素-1β及肿瘤坏死因子-α表达的影响[J].中国康复理论与实践,2014,20(2):121-124.
[10]王朴,刘遄,阳筱甜,等.体外冲击波对兔膝骨关节炎软骨保护和软骨下骨重塑的作用与机制研究[J].四川大学学报(医学版),2014,45(1):120-125.
[11]孟岚,樊啸.玻璃酸钠注射配合体外冲击波治疗膝骨关节炎的临床观察[J].中国康复理论与实践,2010,16(8):713-715.
[12]顾新丰,何杰,张琥,等.透明质酸钠治疗膝骨关节炎的疗效及其影响因素分析[J].中华关节外科杂志(电子版),2016,10(3):255-259.
[13]王江山,何明伟,倪家骧.体外冲击波疼痛治疗的进展[J].中国康复医学杂志,2011,26(8):788-791.
[14]Kawcak CE,Frisbie DD,McIlwraith CW.Effects of extracorporeal shock wave therapy and polysulfated glycosaminoglycan treatment on subchondral bone,serum biomarkers,and synovial fluid biomarkers in horses with induced osteoarthritis[J].Am J Vet Res,2011,72(6):772-779.
[15]Li Y,Xie J,Xu X,et al.Inducible interleukin 32(IL-32) exerts extensive antiviral function via selective stimulation of interferon λ1(IFN-λ1)[J].J Biol Chem,2013,288(29):20927-20941.
[16]Joosten LA,Netea MG,Kim SH,et al.IL-32,a proinflammatory cytokine in rheumatoid arthritis[J].Proc Natl Acad Sci U S A,2006,103(9):3298-3303.
[17]许德世.骨关节炎早期软骨退变关节液中IL-32的意义[J].现代诊断与治疗,2013,24(14):3228-3230.
[18]Pickarski M,Hayami T,Zhuo Y,et al.Molecular changes in articular cartilage and subchondral bone in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis[J].BMC Musculoskelet Disord,2011(12):197.
[19]Blom AB,van Lent PL,van der Kraan PM,et al.To seek shelter from the WNT in osteoarthritis? WNT-signaling as a target for osteoarthritis therapy[J].Curr Drug Targets,2010,11(5):620-629.
[20]姜博,廉永云.Dkk-1蛋白的研究现状、进展及临床意义[J].医学与哲学(B),2012,33(1):36-38.
[21]熊健斌,彭伟秋,孙宏志.Dkk-1干预对骨关节炎的治疗作用[J].广西医科大学学报,2014,31(5):738-740.
[22]Oh H,Chun CH,Chun JS.Dkk-1 expression in chondrocytes inhibits experimental osteoarthritic cartilage destruction in mice[J].Arthritis Rheum,2012,64(8):2568-2578.
[23]Lane NE,Nevitt MC,Lui LY,et al.Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women[J].Arthritis Rheum,2007,56(10):3319-3325.